Search Results

You are looking at 61 - 70 of 1,411 items for :

  • "carcinoma" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Ten Years of Progress in Renal Cell Carcinoma

Eric Jonasch and Robert J. Motzer

In the past 10 years, much has changed in the management of advanced renal cell carcinoma (RCC; Figure 1 ). The treatment of early-stage disease has become less morbid, with the widespread adoption of robotic surgical techniques and the increased

Full access

Treatment Options for Merkel Cell Carcinoma

Samuel W. Beenken and Marshall M. Urist

No benefits or funds were received in support of this study. References 1 Toker C . Trabecular carcinoma of the skin . Arch Dermatol 1972 ; 105 : 107 – 110 . 2 Medina-Franco H Urist MM Fiveash J . Multimodality

Full access

Geographic Variations of Potentially Curative Treatments for Hepatocellular Carcinoma in the United States: A SEER-Medicare Study

En Cheng, Peiyin Hung, and Shi-Yi Wang

Background Hepatocellular carcinoma (HCC) is the dominant histologic type of liver cancer, affecting approximately 20,000 Americans annually. 1 HCC incidence and mortality have been increasing in the United States during the past 3 decades. 2

Full access

Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy

Carlotta Palumbo, Francesco A. Mistretta, Sophie Knipper, Angela Pecoraro, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Claudio Simeone, Alberto Briganti, Alessandro Antonelli, and Pierre I. Karakiewicz

-up have a higher probability of remaining disease-free. 1 However, the magnitude of improved survival is difficult to estimate. Two studies 2 , 3 address cancer-specific CS in patients with nonmetastatic renal cell carcinoma (nmRCC): one is a population

Full access

Management of Renal Cell Carcinoma

Presented by: Michael Serzan

Adjuvant Therapy for Clear Cell Renal Cell Carcinoma Vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) have been extensively studied in the adjuvant setting for patients with renal cell carcinoma (RCC). Although

Full access

CRE24-049: Extrapulmonary Small Cell Carcinoma of Gallbladder Presenting as Acute Cholecystitis

Cindy Iwuagwu, Sesha Sai Kanakamedala, Sarah Tinsley, and Jamal Mohsin

Introduction: Small cell carcinoma (SCC) of the gallbladder is a rare and highly aggressive malignancy, characterized by early metastasis and a grim prognosis. Patients often present aggressive symptoms at an advanced stage of the disease

Full access

Patients With cT1N0M0 Oral Squamous Cell Carcinoma Benefit From Elective Neck Dissection: A SEER-Based Study

Alimujiang Wushou, Meng Wang, Feiluore Yibulayin, Lei Feng, Meng-meng Lu, Yuan Luo, Hui Liu, and Zhi-cheng Yang

Background Oral squamous cell carcinoma (OSCC) is among the most common cancers worldwide, with approximately 369,000 new cases reported in 2012, and increasing each year. 1 As presented in the NCCN Clinical Practice Guidelines in

Full access

Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors

Oscar Hou In Chou, Jing Ning, Raymond Ngai Chiu Chan, Cheuk To Chung, Helen Huang, Kenrick Ng, Edward Christopher Dee, Sharen Lee, Apichat Kaewdech, Ariel K Man Chow, Nancy Kwan Man, Tong Liu, Fengshi Jing, Bernard Man Yung Cheung, Gary Tse, and Jiandong Zhou

Background Over the past several decades, the incidence of hepatocellular carcinoma (HCC) has continued to increase. 1 In 2020, HCC was the sixth most common cancer worldwide, accounting for most cases of liver cancers, and was ranked the third

Full access

Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus

Pablo Maroto, Georgia Anguera, Juan Maria Roldan-Romero, Maria Apellániz-Ruiz, Ferran Algaba, Jacqueline Boonman, Mark Nellist, Cristina Montero-Conde, Alberto Cascón, Mercedes Robledo, and Cristina Rodríguez-Antona

Chromophobe renal cell carcinoma (chRCC) is the third most frequent kidney cancer histologic subtype, accounting for approximately 5% of all RCC cases. At diagnosis, chRCC is generally confined to the kidney but can metastasize. At advanced stages

Full access

CRE24-036: Liver-ing on a Prayer: A Rare Case of Hepatocellular Carcinoma With Metastasis to the Thyroid

Rachel Truong, Odelvys Granela, Shelby Ploucher, Alyssa Obermiller, T. Van Anh, Brian Shaw, and Jacqueline N. Kropf

Liver cancer is thought to be the sixth most diagnosed cancer and is among the top five causes of cancer death globally. Hepatocellular carcinoma (HCC) accounts for up to 90% of primary liver neoplasms in adults. The incidence of thyroid